Alogabat
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alogabat, covering 2025-12-04 to 2025-12-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. [Phase 2]